How can an adult male increase the duration of sexual intercourse?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Increase Sexual Duration

If you are asking about erectile dysfunction (difficulty achieving or maintaining erections), start with a PDE5 inhibitor like tadalafil or sildenafil as first-line therapy; if you are asking about premature ejaculation (ejaculating too quickly), use selective serotonin reuptake inhibitors (SSRIs) or topical anesthetics as first-line treatment. 1, 2, 3

Clarifying the Problem: Two Different Conditions

The question "how to increase sexual time" typically refers to one of two distinct conditions:

  • Erectile dysfunction (ED): Difficulty achieving or maintaining erections sufficient for intercourse 1
  • Premature ejaculation (PE): Ejaculating before desired, typically within 1-2 minutes of penetration 1, 2

These require completely different treatment approaches and should not be confused.


For Erectile Dysfunction: Increasing Ability to Maintain Erections

First-Line Treatment: PDE5 Inhibitors

Start with either tadalafil or sildenafil—both have equivalent efficacy (~69% success rate vs 33% placebo) and should be chosen based on lifestyle preferences. 1, 4, 5

Choosing Between Medications

  • Choose tadalafil if you value spontaneous sexual activity without timing medication (effective up to 36 hours), or if you have coexisting benign prostatic hyperplasia symptoms 4, 5
  • Choose sildenafil if you prefer scheduled sexual activity with a predictable 4-5 hour window, or if there is concern about potential need for emergency nitrates (shorter waiting time of 24 hours vs 48 hours) 5, 6

Critical Safety Screening Before Starting

Verify the patient is NOT taking nitrates in any form—this combination causes potentially fatal hypotension. 4

  • Ask if the patient can walk 1 mile in 20 minutes or climb 2 flights of stairs without symptoms—if unable, refer to cardiology before prescribing 4
  • High-risk patients who should defer treatment include those with unstable angina, uncontrolled hypertension, recent MI, NYHA Class II-IV heart failure, or severe valvular disease 5

Dosing Strategy

  • Tadalafil: Start 10 mg as-needed OR 2.5-5 mg daily for spontaneous activity 4
    • Tadalafil does NOT show dose-dependent improvement between 5 mg, 10 mg, and 20 mg—choose dose based on tolerability, not expecting dramatically better efficacy at higher doses 4
  • Sildenafil: Start 50 mg as-needed (more effective than 25 mg, though 100 mg shows minimal additional benefit over 50 mg) 5, 6

Ensuring an Adequate Trial Before Declaring Failure

Complete at least 5 separate attempts at maximum tolerated dose with proper technique before concluding the medication is ineffective. 4

Before escalating dose or switching medications, systematically address these modifiable factors:

  • Verify adequate sexual stimulation is occurring—PDE5 inhibitors require sexual arousal to work; they do not create spontaneous erections 4
  • Check timing and food intake—taking medication with large or fatty meals reduces efficacy 4
  • Assess alcohol consumption—heavy alcohol use impairs erectile function independent of medication 4, 6
  • Screen for hormonal abnormalities—check morning testosterone levels, as men with testosterone deficiency respond less robustly to PDE5 inhibitors alone 1, 4
  • Evaluate relationship issues—depression, anxiety, and partner conflict significantly impact treatment response 4
  • Review concomitant medications—antihypertensives, antidepressants, and opioids can worsen erectile dysfunction 4

When to Add Testosterone Therapy

For men with testosterone deficiency (typically <300 ng/dL), combining a PDE5 inhibitor with testosterone therapy is more effective than PDE5 inhibitor alone. 4, 5

  • Check morning total testosterone, free testosterone, and SHBG levels 4
  • Testosterone therapy alone is NOT effective monotherapy for ED 4

When to Switch to Another PDE5 Inhibitor

Switch from one PDE5 inhibitor to another only after:

  • Completing maximum-dose regimen for at least 5 attempts 4
  • All modifiable factors have been addressed 4
  • Testosterone supplementation has been evaluated when levels are low 4

Some men who fail one PDE5 inhibitor achieve successful response with another, though head-to-head trials show comparable efficacy. 4

Second-Line Therapies

Proceed to second-line options only after failure of at least two different PDE5 inhibitors at maximum dose with proper technique: 4

  • Intracavernosal injection therapy (alprostadil, papaverine, phentolamine)—most effective non-surgical option but highest risk of priapism 4
  • Vacuum erection devices—mechanical solution with no systemic side effects 4
  • Intraurethral alprostadil suppositories—less effective than injections but less invasive; first administration should be supervised due to ~3% risk of syncope 4
  • Penile prosthesis implantation—definitive surgical solution for refractory cases 4

Common Adverse Effects

Most common side effects include headache, flushing, rhinitis, and dyspepsia; serious adverse events occur in <2% of patients. 1, 6

  • Tadalafil has significantly lower rates of flushing compared to sildenafil 4
  • Myalgia and back pain are more common with tadalafil 4

For Premature Ejaculation: Increasing Time to Ejaculation

Understanding the Condition

Premature ejaculation is defined as ejaculating within 1-2 minutes of penetration with associated distress; the median ejaculatory latency time in Western countries is 5-6 minutes. 1

Men with latencies beyond 25-30 minutes who report distress qualify for delayed ejaculation, which is a different condition. 1

First-Line Treatment Options

Pharmacologic Approaches

Selective serotonin reuptake inhibitors (SSRIs), topical anesthetics, and PDE5 inhibitors all demonstrate significant improvements of 1-5 minutes in intravaginal ejaculatory latency time. 2, 3

  • Dapoxetine (SSRI specifically approved for PE in Europe): Improves perceived control over ejaculation, with 36.3% of men on 30 mg and 44.5% on 60 mg reporting two-category or greater increase in control vs 15% with placebo 7

    • However, discontinuation rates are high (up to 90%) due to side effects, cost, and need for scheduling sexual intercourse 2
  • Topical lidocaine/prilocaine spray (Fortacin): Officially approved in Europe as second medication for PE; offers easy handling and customer-friendly application 2

    • May become real first-line therapy option due to unique galenic preparation and high patient acceptance 2
  • PDE5 inhibitors: Effective for PE, particularly when combined with other therapies 3

  • Tricyclic antidepressants and opioid analgesics: Also demonstrate efficacy but with different side effect profiles 3

Daily vs On-Demand Treatment

The majority of men with lifelong PE (81%) prefer daily drug treatment over on-demand medication, primarily because daily treatment does not interfere with spontaneity of sexual activity. 8

  • Around 60% of men do not care that the medication is an antidepressant 8
  • After receiving information about efficacy and side effects, even more men switch preference to daily treatment 8

Behavioral and Psychological Interventions

Refer men with lifelong or acquired delayed ejaculation to a mental health professional with expertise in sexual health. 1

  • Psycho-behavioral strategies enhance psychosexual arousal and remove barriers that interfere with excitement 1
  • Modifying sexual positions or practices to increase arousal may be beneficial 1
  • Combined drug and behavioral therapies demonstrate significant improvements 3

Combination Therapy

Combining pharmacologic interventions (such as SSRIs or topical anesthetics) with behavioral therapy is more effective than either approach alone. 3

  • Topical lidocaine-prilocaine spray has potential to become established second-line therapy for severe PE patients with ejaculatory latency <1-2 minutes when combined with oral therapy 2

Important Considerations

Pharmacologic interventions or combined therapies are more effective than non-pharmacologic interventions alone for treating sexual dysfunction in men. 3

  • However, evidence for behavioral and psychological interventions is insufficient compared to drug trials, highlighting need for larger randomized controlled trials 3
  • A range of treatment options should be presented to individual patients so they may consider risks and benefits differently 3

Addressing Underlying Issues

Review medications that may contribute to delayed ejaculation and consider replacement, dose adjustment, or staged cessation. 1

  • Check morning testosterone levels, as lower serum testosterone is associated with increased prevalence of delayed ejaculation symptoms 1
  • Basic serum studies including electrolytes, lipids, and glycosylated hemoglobin may identify medical conditions predisposing to neuropathy or vascular disease 1

Biopsychosocial Approach: Beyond Medication

Male sexuality becomes less predictable and more dependent on partner interaction with aging—this transition is normal and does not always require pharmacologic treatment. 9

A purely medical approach fails to address the multidimensional nature of male sexuality and reinforces sex as intercourse performance. 9

  • Realistic expectations should be integrated with therapeutic interventions 9
  • Partner interaction becomes increasingly important as autonomous, predictable erections of adolescence and early adulthood transition to arousal requiring more stimulation 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.